Archive
Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs
Amgen to acquire Dark Blue Therapeutics for up to $840M
FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx
Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO
Amgen describes new GTPase KRAS mutant inhibitors
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
Cytiva Subsidiary Seeks to Quash Subpoena Issued in Amgen’s US Denosumab Litigation Against Accord & Intas - Pearce IP
Directory
59 All
Thermo Fisher
News Danaher
News Agilent
News Merck KGaA
News Illumina
News Waters
News Bruker
News Sartorius
News Mettler Toledo
News PerkinElmer (Revvity)
News Bio-Rad
News Carl Zeiss
News Nikon
News Eppendorf
News Corning
News BD (Becton Dickinson)
News Qiagen
News MGI Tech (华大智造)
News Haier Biomedical
News Lonza
News WuXi AppTec (药明康德)
News WuXi Biologics
News Charles River
News Catalent
News Samsung Biologics
News IQVIA
News LabCorp
News Eurofins
News Pharmaron (康龙化成)
News Pfizer
News Roche
News Merck & Co. (MSD)
News Novartis
News Eli Lilly
News Novo Nordisk
News Moderna
News BioNTech
News Amgen
News BeiGene (百济神州)
News Vertex
News Schrödinger
News Recursion
News Exscientia
News Insilico Medicine
News XtalPi (晶泰科技)
News NVIDIA Healthcare
News DeepMind (Google)
News Medtronic
News Siemens Healthineers
News GE HealthCare
News Philips
News Abbott
News Intuitive Surgical
News Boston Scientific
News Edwards Lifesciences
News Mindray (迈瑞)
News United Imaging (联影)
News Sysmex
News Hologic
News